Do Options Traders Know Something About Chevron Stock We Don't?
Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
Clearly, options traders are pricing in a big move for Chevron shares, but what is the fundamental picture for the company? Currently, Chevron is a Zacks Rank #5 (Sell) in the Oil and Gas - Integrated – International industry that ranks in the Bottom 5% of our Zacks Industry Rank. Over the last 30 days, one analyst has increased the earnings estimates for the current quarter, while two have dropped their estimates. The net effect has taken our Zacks Consensus Estimate for the current quarter from $1.79 per share to $1.58 in that period.
Given the way analysts feel about Chevron right now, this huge implied volatility could mean there's a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. In addition to impressive profit potential, these trades can actually reduce your risk.
Click to see the trades now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Chevron Corporation (CVX) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Eastern Bankshares, Inc. (EBC) Beats Q2 Earnings and Revenue Estimates
Eastern Bankshares, Inc. (EBC) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.22 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +7.89%. A quarter ago, it was expected that this company would post earnings of $0.33 per share when it actually produced earnings of $0.34, delivering a surprise of +3.03%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Eastern Bankshares, which belongs to the Zacks Banks - Northeast industry, posted revenues of $244.9 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 2.71%. This compares to year-ago revenues of $154 million. The company has topped consensus revenue estimates two times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Eastern Bankshares shares have lost about 6.1% since the beginning of the year versus the S&P 500's gain of 8.1%. What's Next for Eastern Bankshares? While Eastern Bankshares has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Eastern Bankshares was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.40 on $242.71 million in revenues for the coming quarter and $1.52 on $977.03 million in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Banks - Northeast is currently in the top 23% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. One other stock from the same industry, Flagstar Financial (FLG), is yet to report results for the quarter ended June 2025. The results are expected to be released on July 25. This bank holding company is expected to post quarterly loss of $0.12 per share in its upcoming report, which represents a year-over-year change of +88.6%. The consensus EPS estimate for the quarter has been revised 27.1% higher over the last 30 days to the current level. Flagstar Financial's revenues are expected to be $525.62 million, down 21.7% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Eastern Bankshares, Inc. (EBC) : Free Stock Analysis Report Flagstar Financial, Inc. (FLG) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Coursera (COUR) Q2 Earnings and Revenues Beat Estimates
Coursera (COUR) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.09 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +33.33%. A quarter ago, it was expected that this online learning platform would post earnings of $0.08 per share when it actually produced earnings of $0.12, delivering a surprise of +50%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Coursera, which belongs to the Zacks Technology Services industry, posted revenues of $187.1 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.38%. This compares to year-ago revenues of $170.34 million. The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Coursera shares have added about 5.4% since the beginning of the year versus the S&P 500's gain of 8.1%. What's Next for Coursera? While Coursera has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Coursera was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.08 on $182.09 million in revenues for the coming quarter and $0.35 on $726.86 million in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Technology Services is currently in the top 34% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. One other stock from the same industry, Bitfarms Ltd. (BITF), is yet to report results for the quarter ended June 2025. This company is expected to post quarterly loss of $0.01 per share in its upcoming report, which represents a year-over-year change of +85.7%. The consensus EPS estimate for the quarter has been revised 40% higher over the last 30 days to the current level. Bitfarms Ltd.'s revenues are expected to be $81.84 million, up 97% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Coursera, Inc. (COUR) : Free Stock Analysis Report Bitfarms Ltd. (BITF) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Compared to Estimates, Edwards Lifesciences (EW) Q2 Earnings: A Look at Key Metrics
Edwards Lifesciences (EW) reported $1.53 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 6.1%. EPS of $0.67 for the same period compares to $0.70 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $1.49 billion, representing a surprise of +2.85%. The company delivered an EPS surprise of +8.06%, with the consensus EPS estimate being $0.62. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance. Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how Edwards Lifesciences performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Net Sales- Europe: $378.2 million versus $353.07 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +12.7% change. Net Sales- Outside of the United States: $642.5 million compared to the $621.76 million average estimate based on two analysts. The reported number represents a change of +12.9% year over year. Net Sales- United States: $889.7 million versus $865.54 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +8.9% change. Net Sales- Japan: $95.3 million compared to the $105.11 million average estimate based on two analysts. The reported number represents a change of +9% year over year. Net Sales- Rest of World: $169 million versus the two-analyst average estimate of $163.59 million. The reported number represents a year-over-year change of +15.7%. Net Sales by Product Group- Transcatheter Mitral and Tricuspid Therapies: $134.5 million versus $129.87 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +62.1% change. Net Sales by Product Group- Surgical Structural Heart: $266.8 million versus the seven-analyst average estimate of $259.33 million. The reported number represents a year-over-year change of +1%. Net Sales by Product Group- Transcatheter Aortic Valve Replacement: $1.13 billion versus $1.1 billion estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +8.9% change. View all Key Company Metrics for Edwards Lifesciences here>>> Shares of Edwards Lifesciences have returned -0.1% over the past month versus the Zacks S&P 500 composite's +5.7% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Edwards Lifesciences Corporation (EW) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
